US tariffs to impact 78% of 510k-approved hospital supplies

Photo from Envato

It will directly impact 66% of supplies manufactured exclusively outside the country.

The hospital supplies sector is expected to face significant losses as US President Donald Trump imposes tariffs affecting up to 78% of all 510k-approved hospital supplies manufactured outside the US, according to Medsource Database by GlobalData.

More specifically, the tariffs will directly impact 66% of 510k-approved hospital supplies manufactured exclusively outside the US.

Meanwhile, retaliatory tariffs from foreign countries are expected to lead to losses for US medical device exporters, potentially reducing foreign investment and driving up domestic prices.

“The ongoing trade war presents a clear risk to medical device manufacturers that produce devices primarily abroad, and they may look to mitigate this risk in the future,” Aidan Robertson, Medical Analyst at GlobalData, said.

“However, the immediate losses incurred by tariffs in the short term will be hard to avoid,” Robertson added.

Join
Healthcare Asia Magazine
community

Since you’re here…

…there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

No Byline Policy

Editorial Guidelines

Corrections Policy

Source